Search Results - "Meza, Jane L"

Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group by MEZA, Jane L, ANDERSON, James, PAPPO, Alberto S, MEYER, William H

“…The outcome for localized rhabdomyosarcoma (RMS) or undifferentiated sarcoma (UDS) is affected by age, histology, primary anatomic site, extent of disease, and…”
Get full text

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group by BEVERLY RANEY, R, WALTERHOUSE, David O, MEZA, Jane L, ANDRASSY, Richard J, BRENEMAN, John C, CRIST, William M, MAURER, Harold M, MEYER, William H, PARHAM, David M, ANDERSON, James R

“…Patients with localized, grossly resected, or gross residual (orbital only) embryonal rhabdomyosarcoma (ERMS) had 5-year failure-free survival (FFS) rates of…”
Get full text

Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma by Lin, Chi, Verma, Vivek, Ly, Quan P., Lazenby, Audrey, Sasson, Aaron, Schwarz, James K., Meza, Jane L., Are, Chandrakanth, Li, Sicong, Wang, Shuo, Hahn, Stephen M., Grem, Jean L.

“…•No studies have assessed SBRT + NFV for borderline/unresectable pancreatic cancer.•This phase I trial enrolled 46 patients, of which 39 received per-protocol…”
Get full text

GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior by Bhat, Aaqib M., Mohapatra, Bhopal C., Luan, Haitao, Mushtaq, Insha, Chakraborty, Sukanya, Kumar, Siddhartha, Wu, Wangbin, Nolan, Ben, Dutta, Samikshan, Storck, Matthew D., Schott, Micah, Meza, Jane L., Lele, Subodh M., Lin, Ming-Fong, Cook, Leah M., Corey, Eva, Morrissey, Colm, Coulter, Donald W., Rowley, M. Jordan, Natarajan, Amarnath, Datta, Kaustubh, Band, Vimla, Band, Hamid

“…While better management of loco-regional prostate cancer (PC) has greatly improved survival, advanced PC remains a major cause of cancer deaths. Identification…”
Get full text

Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: A report from the Children's Oncology Group by Withycombe, Janice S., Smith, Lynette M., Meza, Jane L., Merkle, Carrie, Faulkner, Melissa Spezia, Ritter, Leslie, Seibel, Nita L., Moore, Ki

“…Background Obesity is a well documented problem associated with childhood acute lymphoblastic leukemia (ALL) with increasing body mass index often observed…”
Get full text

Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program by Luan, Haitao, Mohapatra, Bhopal, Bielecki, Timothy A, Mushtaq, Insha, Mirza, Sameer, Jennings, Tameka A, Clubb, Robert J, An, Wei, Ahmed, Dena, El-Ansari, Rokaya, Storck, Matthew D, Mishra, Nitish K, Guda, Chittibabu, Sheinin, Yuri M, Meza, Jane L, Raja, Srikumar, Rakha, Emad A, Band, Vimla, Band, Hamid

“…CHIP/STUB1 ubiquitin ligase is a negative co-chaperone for HSP90/HSC70, and its expression is reduced or lost in several cancers, including breast cancer…”
Get full text

EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry by Luan, Haitao, Bielecki, Timothy A, Mohapatra, Bhopal C, Islam, Namista, Mushtaq, Insha, Bhat, Aaqib M, Mirza, Sameer, Chakraborty, Sukanya, Raza, Mohsin, Storck, Matthew D, Toss, Michael S, Meza, Jane L, Thoreson, Wallace B, Coulter, Donald W, Rakha, Emad A, Band, Vimla, Band, Hamid

“…With nearly all cancer deaths a result of metastasis, elucidating novel pro-metastatic cellular adaptations could provide new therapeutic targets. Here, we…”
Get full text

The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database by Amin, Saber, Baine, Michael J., Meza, Jane L., Lin, Chi

“…Background: Immunotherapy has shown great success in various malignancies. However, its efficacy in pancreatic ductal adenocarcinoma (PDAC) remains a…”
Get full text

Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania by Gesink, Mariah P, Chamberlain, Robert M, Mwaiselage, Julius, Kahesa, Crispin, Jackson, Kahima, Mueller, William, Meza, Jane L, Soliman, Amr S

“…Cervical cancer is the most common cancer among women in Sub-Saharan countries, including Tanzania. While early detection and diagnosis are available in some…”
Get full text

Availability and Use of Palliative Care and End-of-Life Services for Pediatric Oncology Patients by JOHNSTON, Donna L, NAGEL, Kim, FRIEDMAN, Debra L, MEZA, Jane L, HURWITZ, Craig A, FRIEBERT, Sarah

“…Palliative care prevents or relieves the symptoms caused by life-threatening medical conditions. Previous surveys have shown both underuse and lack of…”
Get full text

Symptom Clusters And Quality Of Life Over 1 Year In Breast Cancer Patients Receiving Adjuvant Chemotherapy by Berger, Ann, Kumar, Gaurav, LeVan, Tricia, Meza, Jane

“…Objective: Evidence is scant regarding symptom clusters and quality of life (QOL) over 1 year in women who receive adjuvant breast cancer chemotherapy (CTX)…”
Get full text

Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial by Gendelman, Howard E., Zhang, Yuning, Santamaria, Pamela, Olson, Katherine E., Schutt, Charles R., Bhatti, Danish, Shetty, Bhagya Laxmi Dyavar, Lu, Yaman, Estes, Katherine A., Standaert, David G., Heinrichs-Graham, Elizabeth, Larson, LuAnn, Meza, Jane L., Follett, Matthew, Forsberg, Erica, Siuzdak, Gary, Wilson, Tony W., Peterson, Carolyn, Mosley, R. Lee

“…A potential therapeutic role for immune transformation in Parkinson’s disease evolves from more than a decade of animal investigations demonstrating regulatory…”
Get full text

MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins by Chaturvedi, Pallavi, Singh, Ajay P, Moniaux, Nicolas, Senapati, Shantibhushan, Chakraborty, Subhankar, Meza, Jane L, Batra, Surinder K

“…MUC4, a transmembrane mucin, is aberrantly expressed in pancreatic adenocarcinomas while remaining undetectable in the normal pancreas. Recent studies have…”
Get full text

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis by Chakraborty, Sukanya, Bhat, Aaqib M., Mushtaq, Insha, Luan, Haitao, Kalluchi, Achyuth, Mirza, Sameer, Storck, Matthew D., Chaturvedi, Nagendra, Lopez-Guerrero, Jose Antonio, Llombart-Bosch, Antonio, Machado, Isidro, Scotlandi, Katia, Meza, Jane L., Ghosal, Gargi, Coulter, Donald W., Jordan Rowley, M., Band, Vimla, Mohapatra, Bhopal C., Band, Hamid

“…Overexpression of the EPS15 Homology Domain containing 1 (EHD1) protein has been linked to tumorigenesis but whether its core function as a regulator of…”
Get full text

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis by SINGH, Ajay P, MONIAUX, Nicolas, CHAUHAN, Subhash C, MEZA, Jane L, BATRA, Surinder K

“…The MUC4 mucin is a high molecular weight membrane-bound glycoprotein. It is aberrantly expressed in pancreatic tumors and tumor cell lines with no detectable…”
Get full text

Effect of Radiotherapy Techniques (IMRT vs. 3D-CRT) on Outcome in Patients With Intermediate-Risk Rhabdomyosarcoma Enrolled in COG D9803—A Report From the Children’s Oncology Group by Lin, Chi, M.D., Ph.D, Donaldson, Sarah S., M.D, Meza, Jane L., Ph.D, Anderson, James R., Ph.D, Lyden, Elizabeth R., M.S, Brown, Christopher K., M.P.H, Morano, Karen, C.M.D, Laurie, Fran, B.S, Arndt, Carola A., M.D, Enke, Charles A., M.D, Breneman, John C., M.D

“…Purpose To compare the dosimetric parameters of intensity-modulated radiotherapy (IMRT) and three-dimensional conformal radiotherapy (3D-CRT) in patients with…”
Get full text

Duration on ART, Alcohol Use and HIV Stage May Predict Risky Sexual Behavior in a Resource-limited Environment: A Cross-sectional Study by New-Aaron, Moses, Kingi, Happiness, Meza, Jane L, Goedert, Martha H, Kibusi, Stephen M, Mkhoi, Mkhoi L, Mayengo, Caroline Damian, Charles, James, Shabani, Siraji, New-Aaron, Temitope O, Sumba, Samwel, Cheney, Anlan

“…The intention of antiretroviral therapy (ART) and regular clinic visits are to engender safe sex attitudes among HIV-infected individuals. However, this may…”
Get more information

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease by CRIST, William M, ANDERSON, James R, LOBE, Thom, WEBBER, Bruce, MAURER, Harold M, DONALDSON, Sarah S, MEZA, Jane L, FRYER, Christopher, RANEY, R. Beverly, RUYMANN, Frederick B, BRENEMAN, John, QUALMAN, Stephen J, WIENER, Eugene, WHARAM, Moody

“…The study goal was to improve outcome in children with rhabdomyosarcoma by comparing risk-based regimens of surgery, radiotherapy (RT) and chemotherapy. Eight…”
Get full text

Changes in Uterine Cancer Incidence Rates in Egypt by Chamberlain, Robert M., Remmenga, Steven, Meza, Jane, Ramadan, Mohamed, Hablas, Ahmed, Soliman, Amr S., Alshahrani, Saad, Seifeldin, Ibrahim A.

“…Background. Uterine cancer is one of the top-ranking cancers in women with wide international variations in incidence rates. Developed countries have higher…”
Get full text

Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease by Heinrichs-Graham, Elizabeth, Wilson, Tony W, Santamaria, Pamela M, Heithoff, Sheila K, Torres-Russotto, Diego, Hutter-Saunders, Jessica A L, Estes, Katherine A, Meza, Jane L, Mosley, R L, Gendelman, Howard E

“…Parkinson's disease (PD) is a neurodegenerative disorder associated with debilitating motor, posture, and gait abnormalities. Human studies recording local…”
Get full text